CMU-Q researchers publish review on new possibilities in cancer therapy

Doha: Ettaib El Marabti, a graduate of Carnegie Mellon University in Qatar (CMU-Q), led a team of researchers in the first comprehensive review of minor intron splicing. Scientific findings in this lesser-studied area of genomics could lead to new approaches in fighting three classes of diseases: cancer, autoimmune disorders and neurological conditions. 

El Marabti graduated from CMU-Q with a bachelor’s degree in biological sciences, and is currently a fourth-year student at Weill Cornell Medicine-Qatar (WCM-Q). Both CMU-Q and WCM-Q are Qatar Foundation partner universities. During his research, El Marabti was guided by CMU-Q’s Ihab Younis, area head of biological sciences, and Joel Malek, director of the genomics laboratory at WCM-Q, who are both co-authors of the review.